Skip to contentA
Astrana Health, Inc.
A
ASTHAstrana Health, Inc. Q2 2021 · 10-Q
Revenue$175.64M$175.64M+6.3% vs Q2 2020 Net Income$10.09M$10.09M+43.2% vs Q2 2020 EPS Diluted$0.22$0.22+15.8% vs Q2 2020 Operating Income$20,988,000+62.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Astrana Health, Inc. · CIK 1083446 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$14,068,000−35.1% Margins · derivedOperating margin11.9%+4.1 pt vs Q2 2020
Net margin5.7%+1.5 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 6, 2021 · 37 d after period end